- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Warner Chilcott PLC
+ Add to WatchlistWCRX:US
19.8300 USD 0.6200 3.23%
Share
As of 11:52:28 ET on 05/20/2013.
More on WCRX
News for Warner Chilcott PLC (WCRX)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Actavis to Buy Warner Chilcott in Women’s Health Effort Updated 1 hour ago
- Teva U.S. Jump Widens Holiday Discount: Israel Overnight
- Actavis Gaining More From Purchase Than Sale: Real M&A
- Actavis Said to Have Spurned $15 Billion Offer From Mylan
- Actavis Says It’s in Early Talks to Buy Warner Chilcott
- U.S. Stock Options With Biggest Changes in Implied Volatility
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Largest Nasdaq Short Interest Percent Decreases as of March 28
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Endo Seen Boosted by Fidelity-Favored Sale: Real M&A
- Fidelity Said to Push Endo Health to Consider a Sale
- Largest Nasdaq Short Interest Changes as of Dec. 31
- U.S. Stock Options With Biggest Changes in Implied Volatility
- Orbimed Advisors LLC Holdings in 3rd Quarter: 13F Alert
- Eton Park Capital Management Holdings in 3rd Quarter: 13F Alert
- Fitch: Warner Chilcott Deal In Line with Actavis' 'BBB-' Ratings Published 20 minutes ago
- IRSH: The Vanguard Group: Form 8.3 - Warner Chilcott Plc Published 1 hour ago
- IRSH: PointState Capital LP: Form 8.3 - Warner Chilcott PLC Published 2 hours ago
- Announcement Under Irish Takeover Rules Revision to Relevant Securities in Issue Published 3 hours ago
- IRSH: BARCLAYS PLC: Form 8.3 - WARNER CHILCOTT PLC Published 3 hours ago
- Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company Published 4 hours ago
- IRSH: BARCLAYS PLC: Form 8.3 - WARNER CHILCOTT PLC Published May 17, 2013
- IRSH: The Vanguard Group: Form 8.3 - Warner Chilcott Plc Published May 17, 2013
- PointState Capital LP: Form 8.3 - Warner Chilcott PLC Published May 17, 2013
- BARC: BARCLAYS PLC: Form 8.3 - Warner Chilcott plc Published May 16, 2013
- The Vanguard Group: Form 8.3 - Warner Chilcott Plc Published May 16, 2013
- IRSH: BARCLAYS PLC: Form 8.3 - WARNER CHILCOTT PLC Published May 15, 2013
- IRSH: The Vanguard Group: Form 8.3 - Warner Chilcott Plc Published May 15, 2013
- IRSH: PointState Capital LP: Form 8.3 - Warner Chilcott PLC Published May 15, 2013
- BARC: BARCLAYS PLC: Form 8.3 - Warner Chilcott plc Published May 15, 2013
- ‘Love Hormone’ Promises Safer Births After Pfizer Flop
- Elan Makes Two Acquisitions for $380 Million
- ThromboGenics Reports Jetrea Sales as Drug Fails Mid-Stage Study
- Eu Yan Sang Jumps Most Since Feb. 2012 on Deal: Singapore Mover
- Algeta Surges to Record After Prostate Cancer Drug Approval
- Chesapeake Partners Holdings in 1st Quarter: 13F Alert
- Bayer, Algeta Win U.S. Approval for Prostate Cancer Drug
- Primecap Rides Health to Top Growth Fund: Riskless Return
- Elan to Pay $1 Billion for Stake in Theravance Royalties
- Glaxo, Theravance Win Approval for Lung Disease Treatment
- Tesla CEO Talking With Google About ‘Autopilot’ Systems
- Tong Ren Tang Chinese Medicine Doubles on Debut: Hong Kong Mover
- Israeli ADHD-Drug Maker Alcobra Seeks $27 Million in IPO
- Novartis Boost Seen in Fast Approvals as Protection Ends
- China Stocks Rebound From 4-Month Low on Financial Shares
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page